Baicalin suppress the development of polycystic ovary syndrome via regulating the miR-874-3p/FOXO3 and miR-144/FOXO1 axis

AbstractContext Polycystic ovary syndrome (PCOS) is a common and complex disease caused by endocrine and metabolic dysfunction in women of reproductive age. Baicalin is reported to ameliorate PCOS.Objective This study determines whether baicalin could affect the progression of PCOS.Materials and met...

Ամբողջական նկարագրություն

Մատենագիտական մանրամասներ
Հիմնական հեղինակներ: Xiaoyuan Xu, Xiaohua Xu, Xiaoshuang Wang, Ling Shen
Ձևաչափ: Հոդված
Լեզու:English
Հրապարակվել է: Taylor & Francis Group 2023-12-01
Շարք:Pharmaceutical Biology
Խորագրեր:
Առցանց հասանելիություն:https://www.tandfonline.com/doi/10.1080/13880209.2023.2208636
_version_ 1827302107869347840
author Xiaoyuan Xu
Xiaohua Xu
Xiaoshuang Wang
Ling Shen
author_facet Xiaoyuan Xu
Xiaohua Xu
Xiaoshuang Wang
Ling Shen
author_sort Xiaoyuan Xu
collection DOAJ
description AbstractContext Polycystic ovary syndrome (PCOS) is a common and complex disease caused by endocrine and metabolic dysfunction in women of reproductive age. Baicalin is reported to ameliorate PCOS.Objective This study determines whether baicalin could affect the progression of PCOS.Materials and methods To establish an animal model of PCOS, female Sprague-Dawley (SD) rats were subcutaneously injected with dehydroepiandrosterone (DHEA, 60 mg/kg) for 20 days. Next, normal and PCOS mice were divided into 3 groups: control, PCOS, PCOS + Baicalin (20 mg/kg) groups. In addition, the levels of microRNA-874-3p (miR-874-3p) and microRNA-144 (miR-144) in ovarian tissues were assessed by reverse transcription-quantitative polymerase chain reaction (RT-qPCR).Results Compared to the PCOS group, baicalin treatment significantly declined free testosterone (33.71 pg/mL vs. 56.05 pg/mL) and luteinizing hormone (LH; 3971.73 pg/mL vs. 5201.50 pg/mL) levels in rats with PCOS. Additionally, compared to the control group, 100 μM baicalin lessened miR-874-3p and miR-144 levels in human ovarian granulosa cells (KGN cells) by 36.87% and 32.57%, respectively. Furthermore, forkhead box O (FOXO) proteins FOXO1 and FOXO3 are the direct targets of miR-144 and miR-874-3p, respectively. Meanwhile, baicalin induced G0-G1 phase arrest (69.56 ± 3.7% at baicalin with 100 μM vs. 51.24 ± 3.2%, control) in KGN cells correlating with decreased p27 Kip1 (FOXO proteins downstream effector gene) expression by 55.5%; however, miR-874-3p or miR-144 overexpression could abolish this effect.Conclusions Baicalin could alleviate the symptoms of PCOS via regulating miR-874-3p/FOXO3 and miR-144/FOXO1 axis, demonstrating its potential utility in PCOS treatment.
first_indexed 2024-03-09T00:09:36Z
format Article
id doaj.art-ca8581294703406a9d35f2d0174cae1f
institution Directory Open Access Journal
issn 1388-0209
1744-5116
language English
last_indexed 2024-04-24T16:38:49Z
publishDate 2023-12-01
publisher Taylor & Francis Group
record_format Article
series Pharmaceutical Biology
spelling doaj.art-ca8581294703406a9d35f2d0174cae1f2024-03-29T11:10:26ZengTaylor & Francis GroupPharmaceutical Biology1388-02091744-51162023-12-0161187888510.1080/13880209.2023.2208636Baicalin suppress the development of polycystic ovary syndrome via regulating the miR-874-3p/FOXO3 and miR-144/FOXO1 axisXiaoyuan Xu0Xiaohua Xu1Xiaoshuang Wang2Ling Shen3Department of Obstetrics and Gynecology, The First Affiliated Hospital of Shantou University Medical College, Shantou, ChinaDepartment of Cardiology, the First People’s Hospital of Jingdezhen, Jingdezhen, ChinaDepartment of Obstetrics and Gynecology, The First Affiliated Hospital of Shantou University Medical College, Shantou, ChinaDepartment of Obstetrics and Gynecology, The First Affiliated Hospital of Shantou University Medical College, Shantou, ChinaAbstractContext Polycystic ovary syndrome (PCOS) is a common and complex disease caused by endocrine and metabolic dysfunction in women of reproductive age. Baicalin is reported to ameliorate PCOS.Objective This study determines whether baicalin could affect the progression of PCOS.Materials and methods To establish an animal model of PCOS, female Sprague-Dawley (SD) rats were subcutaneously injected with dehydroepiandrosterone (DHEA, 60 mg/kg) for 20 days. Next, normal and PCOS mice were divided into 3 groups: control, PCOS, PCOS + Baicalin (20 mg/kg) groups. In addition, the levels of microRNA-874-3p (miR-874-3p) and microRNA-144 (miR-144) in ovarian tissues were assessed by reverse transcription-quantitative polymerase chain reaction (RT-qPCR).Results Compared to the PCOS group, baicalin treatment significantly declined free testosterone (33.71 pg/mL vs. 56.05 pg/mL) and luteinizing hormone (LH; 3971.73 pg/mL vs. 5201.50 pg/mL) levels in rats with PCOS. Additionally, compared to the control group, 100 μM baicalin lessened miR-874-3p and miR-144 levels in human ovarian granulosa cells (KGN cells) by 36.87% and 32.57%, respectively. Furthermore, forkhead box O (FOXO) proteins FOXO1 and FOXO3 are the direct targets of miR-144 and miR-874-3p, respectively. Meanwhile, baicalin induced G0-G1 phase arrest (69.56 ± 3.7% at baicalin with 100 μM vs. 51.24 ± 3.2%, control) in KGN cells correlating with decreased p27 Kip1 (FOXO proteins downstream effector gene) expression by 55.5%; however, miR-874-3p or miR-144 overexpression could abolish this effect.Conclusions Baicalin could alleviate the symptoms of PCOS via regulating miR-874-3p/FOXO3 and miR-144/FOXO1 axis, demonstrating its potential utility in PCOS treatment.https://www.tandfonline.com/doi/10.1080/13880209.2023.2208636Endocrine and metabolic dysfunctionmiRNAScutellaria baicalensis
spellingShingle Xiaoyuan Xu
Xiaohua Xu
Xiaoshuang Wang
Ling Shen
Baicalin suppress the development of polycystic ovary syndrome via regulating the miR-874-3p/FOXO3 and miR-144/FOXO1 axis
Pharmaceutical Biology
Endocrine and metabolic dysfunction
miRNA
Scutellaria baicalensis
title Baicalin suppress the development of polycystic ovary syndrome via regulating the miR-874-3p/FOXO3 and miR-144/FOXO1 axis
title_full Baicalin suppress the development of polycystic ovary syndrome via regulating the miR-874-3p/FOXO3 and miR-144/FOXO1 axis
title_fullStr Baicalin suppress the development of polycystic ovary syndrome via regulating the miR-874-3p/FOXO3 and miR-144/FOXO1 axis
title_full_unstemmed Baicalin suppress the development of polycystic ovary syndrome via regulating the miR-874-3p/FOXO3 and miR-144/FOXO1 axis
title_short Baicalin suppress the development of polycystic ovary syndrome via regulating the miR-874-3p/FOXO3 and miR-144/FOXO1 axis
title_sort baicalin suppress the development of polycystic ovary syndrome via regulating the mir 874 3p foxo3 and mir 144 foxo1 axis
topic Endocrine and metabolic dysfunction
miRNA
Scutellaria baicalensis
url https://www.tandfonline.com/doi/10.1080/13880209.2023.2208636
work_keys_str_mv AT xiaoyuanxu baicalinsuppressthedevelopmentofpolycysticovarysyndromeviaregulatingthemir8743pfoxo3andmir144foxo1axis
AT xiaohuaxu baicalinsuppressthedevelopmentofpolycysticovarysyndromeviaregulatingthemir8743pfoxo3andmir144foxo1axis
AT xiaoshuangwang baicalinsuppressthedevelopmentofpolycysticovarysyndromeviaregulatingthemir8743pfoxo3andmir144foxo1axis
AT lingshen baicalinsuppressthedevelopmentofpolycysticovarysyndromeviaregulatingthemir8743pfoxo3andmir144foxo1axis